Last reviewed · How we verify
NCT05292300
Efficacy of Lyophilized Dried Cornus Mas L. on Anthropometric and Biochemical Parameters in Insulin Resistance
NA trial testing Cornelian Cherry (Cornus mas L.) in Insulin Resistance in 84 participants. Completed in 30 July 2022.
30 April 2022
Quick facts
| Lead sponsor | Marmara University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 84 |
| Start date | 24 May 2021 |
| Primary completion | 30 April 2022 |
| Estimated completion | 30 July 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Cornelian Cherry (Cornus mas L.)
- Diet
Conditions studied
- Insulin Resistance — all drugs for Insulin Resistance →
- Obesity — all drugs for Obesity →
- PreDiabetes — all drugs for PreDiabetes →
Sponsor
Marmara University
Who can join
Adults 18 to 45, female only, with Insulin Resistance or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determine the effect of 3 months supplementation of lyophilize dried cornelian cherry (Cornus mas L.) on women diagnosed with insulin resistance. The baseline and end biochemical parameters and anthropometric measurements will be compared with control subjects.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The effect of lyophilized dried cornelian cherry (<i>Cornus mas</i> L.) intake on anthropometric and biochemical parameters in women with insulin resistance: A randomized controlled trial.
Celık ZM, Sargin M, Tamer HG, Gunes FE. · · 2023 · cited 5× · PMID 38107130 · DOI 10.1002/fsn3.3725 -
Evidence-Based Anti-Diabetic Properties of Plant from the Occitan Valleys of the Piedmont Alps.
Boscaro V, Rivoira M, Sgorbini B, Bordano V, et al · · 2022 · cited 4× · PMID 36365189 · DOI 10.3390/pharmaceutics14112371
Verify or expand the search:
- PubMed search for NCT05292300
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insulin Resistance
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
- NCT07505745 — MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity · Phase 2 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
Other Marmara University trials
Trials by the same sponsor.
- NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke · NA · not yet recruiting
- NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students · NA · not yet recruiting
- NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery · NA · not yet recruiting
- NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
- NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05292300 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marmara University
- Last refreshed: 29 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05292300.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing